Inotiv Inc (NOTV)
4.27
+0.11
(+2.64%)
USD |
NASDAQ |
May 03, 16:00
4.27
0.00 (0.00%)
After-Hours: 20:00
Inotiv Price to Book Value: 0.4333 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 0.4333 |
May 02, 2024 | 0.4221 |
May 01, 2024 | 0.3978 |
April 30, 2024 | 0.3897 |
April 29, 2024 | 0.3795 |
April 26, 2024 | 0.411 |
April 25, 2024 | 0.4353 |
April 24, 2024 | 0.4739 |
April 23, 2024 | 0.4921 |
April 22, 2024 | 0.4485 |
April 19, 2024 | 0.4384 |
April 18, 2024 | 0.4769 |
April 17, 2024 | 0.55 |
April 16, 2024 | 0.5703 |
April 15, 2024 | 0.5713 |
April 12, 2024 | 0.6048 |
April 11, 2024 | 0.6687 |
April 10, 2024 | 0.7225 |
April 09, 2024 | 0.7499 |
April 08, 2024 | 0.7438 |
April 05, 2024 | 0.7245 |
April 04, 2024 | 0.7296 |
April 03, 2024 | 0.9599 |
April 02, 2024 | 0.963 |
April 01, 2024 | 1.002 |
Date | Value |
---|---|
March 28, 2024 | 1.110 |
March 27, 2024 | 1.081 |
March 26, 2024 | 1.019 |
March 25, 2024 | 1.120 |
March 22, 2024 | 1.080 |
March 21, 2024 | 1.015 |
March 20, 2024 | 0.9762 |
March 19, 2024 | 0.9173 |
March 18, 2024 | 0.9082 |
March 15, 2024 | 0.9265 |
March 14, 2024 | 0.8392 |
March 13, 2024 | 0.8402 |
March 12, 2024 | 0.8514 |
March 11, 2024 | 0.7742 |
March 08, 2024 | 0.8595 |
March 07, 2024 | 0.8067 |
March 06, 2024 | 0.8412 |
March 05, 2024 | 0.8108 |
March 04, 2024 | 0.7793 |
March 01, 2024 | 0.8108 |
February 29, 2024 | 0.756 |
February 28, 2024 | 0.6657 |
February 27, 2024 | 0.6707 |
February 26, 2024 | 0.6515 |
February 23, 2024 | 0.5662 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1619
Minimum
Nov 10 2023
70.28
Maximum
Jun 17 2021
6.434
Average
2.018
Median
Jul 03 2019
Price to Book Value Benchmarks
Avid Bioservices Inc | 2.907 |
Macrogenics Inc | 6.410 |
Synlogic Inc | 0.5024 |
BioXcel Therapeutics Inc | -- |
IGM Biosciences Inc | 2.913 |
Price to Book Value Related Metrics
PS Ratio | 0.1878 |
Price to Free Cash Flow | 27.19 |
Price | 4.27 |
Earnings Yield | -30.44% |
Market Cap | 110.13M |
Operating PE Ratio | 20.15 |